M

Melinta Therapeutics

156 employees

Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Emergency Medicine
Health Care
Antibiotics
Antimicrobials
Acute Care
Pharmaceutical

Date founded

2000

Funding rounds raised

Total raised

$90M

from 10 investors over 10 rounds

M

Melinta Therapeutics raised $6.2M on May 7, 2018

Investors: CARB-X

M

Melinta Therapeutics raised $90M on June 29, 2017

Investors: Oberland Capital

M

Melinta Therapeutics raised $67M on June 10, 2015

Investors: Malin Corporation plc and Vatera Healthcare Partners

M

Melinta Therapeutics raised $30M on February 9, 2015

Investors: Hercules Capital, Inc.

M

Melinta Therapeutics raised $70M on February 10, 2014

Investors: Vatera Healthcare Partners

M

Melinta Therapeutics raised $68M on November 29, 2012

Investors: ABS Ventures, Vatera Healthcare Partners and Warburg Pincus LLC

M

Melinta Therapeutics raised $20M on January 11, 2011

Investors: Warburg Pincus LLC

FAQ